Neoplasia/BPH

	Effect of co-occurring mutations in TP53 gene and TERT promoter on the survival of bladder cancer patients. Front Immunol Tornesello ML, Piccirillo MC, Tambaro R, Simeon V. PMID: 41878440 [PubMed - indexed for MEDLINE]
	Multicentre Evaluation of an AI-Assisted Urine Test for Clinically Significant Prostate Cancer in Men Undergoing Initial Biopsy. J Extracell Vesicles Jiang S, Yang C, Huang Z, Guo Z, Lu F, Nian X, Chen Z, Luo P, Jiang J, Gao X, Li M, Liu F. PMID: 41877634 [PubMed - indexed for MEDLINE]
	Empirically derived dietary patterns and prostate cancer risk: a systematic review and meta-analysis of prospective cohorts. Eur J Cancer Prev Ben Souilah F, Tourigny R, Drouin-Chartier JP, Diorio C, Fradet V. PMID: 41877536 [PubMed - as supplied by publisher]
	Deciphering double-negative prostate cancer: from aggressive subtype to novel therapeutic paradigms. Cell Commun Signal Wang J, Wu R, Tuo Z, Okoli UA, Wang Z, Chaipanichkul P, Koh SB, Li D, Lyu Z, Umber C, Zhang Q, Feng D. PMID: 41877195 [PubMed - as supplied by publisher]
	Stage-specific associations of HER2 overexpression with clinical and pathological features in bladder cancer: a systematic review and meta-analysis. Int Urol Nephrol Guo C, Wei J, Wang Y, Zhang L, Wu X, Sheng X. PMID: 41876828 [PubMed - as supplied by publisher]
	Evaluating the safety profile of Î±-1 blockers, 5Î±-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS). Aging Male Zhao Z, Wu C, Xiong Y, Wang W, Qin F, Yuan J. PMID: 41876378 [PubMed - indexed for MEDLINE]
	Characterization of Immune Infiltrating Cells in Bladder Urothelial Carcinoma and Its Clinical Significance. Cancer Med Yan X, Tang X, Guo L, He Z, Liu S, Wu S, Li Z, Liu TZ, Zheng H, Zhang W, Li S. PMID: 41876361 [PubMed - indexed for MEDLINE]
	Two-year toxicity and PSA dynamics in the initial cohort of the SABR-Dual trial - two-fraction stereotactic radiotherapy for localized prostate cancer using rectal spacing. Radiother Oncol Fredman E, Attrash M, Yosefof E, Moore A, Tschernichovsky R, Bragilovski D, Weinstock-Sabbah M, Kindler J, Azuz RD, Radus R, Icht O, Golan S, Shochet T, Limon D. PMID: 41876028 [PubMed - as supplied by publisher]
	[Early Detection of Prostate Cancer: Current Real-World Data from the VERSUS Study by d-uo]. Aktuelle Urol Doehn C, König F, Johannsen M, Eichenauer R, Schönfelder R, Doehn ML, Schröder J, Hempel E, Klier J. PMID: 41875916 [PubMed - as supplied by publisher]
	AI chatbots for patient education in localized prostate cancer radiotherapy: A comparative quality and readability analysis. Patient Educ Couns Ozturk GA, Tumer EG, Çoban FSK, Ozturk H, Gurlek U, Ozturk M, Demirci H. PMID: 41875785 [PubMed - as supplied by publisher]
	Potential of the signature index (S-index), a diffusion MRI Biomarker, to enhance diagnosis of clinically significant prostate cancer and decrease the rate of unnecessary biopsies. Eur J Radiol Wibulpolprasert P, Bihan DL, Leelarujijaroen P, Kampaengtip A, Kijvikai K, Worawichawong S, Phongkitkarun S. PMID: 41875674 [PubMed - as supplied by publisher]
	A Culturally Tailored Mobile Health Intervention to Improve Quality of Life in Black Survivors With Prostate Cancer: Protocol for a Stratified Randomized Controlled Trial. JMIR Res Protoc Kumar G, Ghasemi P, Alexander AC, Dwyer K, Neil JM, Cole P, Beckford P, Reese D, Montgomery E, Odeleye R, Harris MA, Zhao YD, Nagykaldi Z, McIntosh AG, Kaninjing E, Young ME, Dickey S, Morton DJ, Bolajoko O, Odedina FT, Planas LG, Businelle MS, Kendzor DE, Ogunsanya ME. PMID: 41875429 [PubMed - indexed for MEDLINE]
	Repositioning the Digital Rectal Examination in the Era of Risk-Adapted Prostate Can-cer Diagnostics: Right Tool to the Right Patient at the Right Time. Int Braz J Urol Reis LO. PMID: 41875312 [PubMed - in process]
	Patient doses in image-guided radiotherapy: status in Europe for cone-beam CT imaging in the pelvic region. Radiol Oncol Kansanoja T, Brovchuk S, Vezirovic M, Petrovic B, Amico AG, Sapignoli S, Paiusco M, Ferrari P, Sá AC, Dias AG, Teles P, Siiskonen T. PMID: 41875062 [PubMed - indexed for MEDLINE]
	Diagnostic performance analysis of two-gene methylation in urothelial carcinoma based on small-volume urine sample. Cancer Wu Z, Cao L, Zeng J, Feng W, Zhou Q, Deng X, Zhang L, Tan X, Wang Y, Cao J, Xie Y, Xu A, Yao K. PMID: 41874814 [PubMed - indexed for MEDLINE]
	Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV). Cancer Immunol Immunother Mollica V, Massari F, Fujita K, Giannatempo P, Grande E, Büttner T, Bourlon MT, Taha T, Fukuokaya W, Myint ZW, Pichler R, Binz K, Molina-Cerrillo J, Kopecky J, de Liaño AG, Kucharz J, Fiala O, Matrana MR, Kopp RM, Di Civita MA, Zgura A, Ansari J, Kihnel R, De Felice F, Angel M, Monteiro FSM, Soares A, Urun Y, Buti S, Santini D, Santoni M. PMID: 41874648 [PubMed - indexed for MEDLINE]
	Artificial intelligence and radiomics in bladder cancer MRI: a scoping review of applications, performance, and barriers to clinical translation. Abdom Radiol (NY) Salvaggio G, Comelli A, Albano D, Galia M, Lalwani N. PMID: 41874614 [PubMed - as supplied by publisher]
	Unclear territory: navigating metastatic nonclear cell renal cell carcinoma. Curr Opin Oncol Goodstein T, Wong V, Montenegro GB, Srinivasan R, Singer EA. PMID: 41874435 [PubMed - as supplied by publisher]
	Short and Long Non-Coding RNAs in Renal Cell Carcinoma. Noncoding RNA Cecati M, Pozzi V, Schiavoni V, Barrasso G, Pompei V, Marzioni D, Bonci N, Fumarola S, Ballini A, Sartini D, Campagna R. PMID: 41874142 [PubMed]
	Prediction Models and Prognostic Analysis of Immune-Related Acute Kidney Injury in Lung Cancer Patients. Technol Cancer Res Treat Qian S, Xu N, Qu Y, Zhu R, Zhang M, Chen K, Wang J, Lu X, Cai K. PMID: 41873485 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 186559

Page 1 of 9328



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy